The Institute for Translational Oncology Research (ITOR) of Greenville Health System (GHS) focuses on discovering and developing drugs that help patients who have cancer.
ITOR of GHS is a crucial resource to physicians and their patients when they have exhausted the normal paths of treatment. By providing some of the most advanced cancer treatments available anywhere in the world while supporting industry's crucial need to achieve greater efficiency and expediency in bringing life-saving cancer drugs to patients, ITOR forges a direct link between basic research and compassionate patient care.
For information about ITOR clinical trials:
For information about ITOR Biorepository Services:
For information about our translational research initiatives:
For general information about ITOR:
For ITOR contact information: